l carnitine usage in treatment of acute valproic acid intoxication L-carnitine for valproic-acid induced toxicity Frontiers | The serum acylcarnitines

[DOI] [PMC free article] [PubMed] [Google Scholar] 43.Fielding R., Riede L., Lugo J.P., Bellamine A

10.1073/pnas.1316569111 Summary Keywords trimethylamine N-oxide, chronic kidney disease, gut microbiota, targeted TMAO drugs, mechanism, treatment Citation Zixin Y, Lulu C, Xiangchang Z, Qing F, Binjie Z, Chunyang L, Tai R and Dongsheng O (2022) TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review

doi: 10.1016/j.ebiom.2018.01.015

This matters because dosing varies dramatically between pharmacies, and without knowing the amount, you cannot evaluate whether it is in the range shown to be effective in research (1,000-2,000 mg daily oral equivalent)

Conversely, patients taking certain anticonvulsants like Valproic Acid may actually require prescribed carnitine to prevent drug-induced depletion